Is Albert Labs International Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Albert Labs International Corp (ABRT.CN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Albert Labs International Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Albert Labs International Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Albert Labs International Corp?

Muslim investors may consider investing in Albert Labs International Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Albert Labs International Corp classified as NOT COVERED?

Musaffa determines the Shariah status of Albert Labs International Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Albert Labs International Corp updated?

The Shariah compliance status of Albert Labs International Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Albert Labs International Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Albert Labs International Corp?

You can check the latest Shariah compliance status of Albert Labs International Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Albert Labs International Corp. Stock Analysis ABRT.CN

Canada N/A Nano Cap

Albert Labs International Corp. operates as a research and drug development company. The firm is focused on active compounds in the treatment of mental health and providing rapid access to effective prescription medicines for people suffering from mental health disorders. The firm operates primarily in one business segment: research and development of drugs to ensure accelerated access to safe and effective psychedelic-assisted therapy for patients with urgent, unmet needs. The firm also focuses on developing solutions through an approved, fast-track clinical pathway focusing on Real World Evidence (RWE). Its first drug target, KRN-101, is a potential solution for cancer-related anxiety. KRN-101 is derived from natural psilocybin mycelium. Through collaborations with research institutions, hospital centers and government agencies, the Company uses existing clinical infrastructure to deliver and improve patient access to its treatment.

Key Statistics of Albert Labs International Corp (ABRT.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.01CAD0.01

Today's Open

CAD0.01

Volume

1000.00

P/E Ratio (TTM)

52 Week Range

CAD0.01CAD0.12

Market Cap

370.00K

Avg. Volume

34.57K

Dividend Yield

Financial Metrics & Statements of Albert Labs International Corp (ABRT.CN)

FAQ's for Albert Labs International Corp (ABRT.CN)

According to Musaffa’s Shariah screening methodology, Albert Labs International Corp (ABRT.CN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.